全球空间体学市场规模、份额、趋势和成长分析报告（2026-2034）

预计空间体学市场将从 2025 年的 8.4 亿美元成长到 2034 年的 34.1 亿美元，2026 年至 2034 年的复合年增长率为 16.81%。

受基因组学和精准医学发展趋势的推动，全球空间体学市场正经历快速成长。空间体学技术使研究人员能够在组织的空间背景下研究基因和蛋白质的表达。这种方法能够深入了解疾病机制，尤其是在癌症研究和神经科学领域。生命科学研究经费的增加和对个人化医疗日益增长的需求是推动市场扩张的关键因素。

製药和生物技术公司正在采用空间体学技术来改善药物发现和开发流程。学术研究机构也大力投资先进的成像技术和定序技术。慢性病发病率的上升以及对精准诊断日益增长的需求进一步推动了这一趋势。成像平台和生物资讯学工具的技术进步正在提高数据准确性和研究效率。

未来几年，随着技术的普及和成本效益的提高，市场预计将显着增长。研究机构与产业界的合作将促进创新，新兴医疗市场的扩张以及政府对基因组研究支持的加强将创造新的机会。随着精准医疗的普及，空间体学将在变革全球医疗保健解决方案方面发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球空间体学市场：依技术划分

• 市场分析、洞察与预测
• 空间转录组学
• 空间基因体学
• 空间蛋白质体学

第五章：全球空间体学市场：依产品划分

• 市场分析、洞察与预测
• 装置
• 消耗品
• 软体

第六章：全球空间体学市场：依工作流程划分

• 市场分析、洞察与预测
• 样品製备
• 仪器分析
• 数据分析

第七章：全球空间体学市场：依样本类型划分

• 市场分析、洞察与预测
• FFPE
• 新鲜和冷冻

第八章：全球空间体学市场：依最终用途划分

• 市场分析、洞察与预测
• 学术研究机构与转化研究机构
• 製药和生物技术公司

第九章：全球空间体学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • 10x Genomics
  • Bio-Techne
  • Bruker
  • Dovetail Genomics
  • S2 Genomics Inc
  • Akoya Biosciences Inc
  • RareCyte Inc
  • Standard BioTools
  • Rebus Biosystems Inc
  • Vizgen Inc

The Spatial Omics Market size is expected to reach USD 3.41 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 16.81% during 2026-2034.

The Global Spatial Omics Market is experiencing rapid growth due to advancements in genomics and precision medicine. Spatial omics technologies allow researchers to study gene and protein expression within the spatial context of tissues. This approach provides deeper insights into disease mechanisms, especially in cancer research and neuroscience. Increasing funding for life sciences research and the rising demand for personalized medicine are major drivers supporting market expansion.

Pharmaceutical and biotechnology companies are adopting spatial omics to improve drug discovery and development processes. Academic research institutions are also investing heavily in advanced imaging and sequencing technologies. The growing prevalence of chronic diseases, along with the need for accurate diagnostics, is further strengthening demand. Technological advancements in imaging platforms and bioinformatics tools are enhancing data accuracy and research efficiency.

In the coming years, the market is expected to grow significantly as technology becomes more accessible and cost-effective. Collaborations between research institutions and industry players will drive innovation. Expansion in emerging healthcare markets and increased government support for genomic research will create new opportunities. As precision medicine becomes more mainstream, spatial omics will play a vital role in transforming healthcare solutions globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

By Product

• Instruments
• Consumables
• Software

By Workflow

• Sample Preparation
• Instrumental Analysis
• Data Analysis

By Sample Type

• FFPE
• Fresh Frozen

By End-use

• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies

COMPANIES PROFILED

• 10x Genomics, BioTechne, Bruker, Dovetail Genomics, S2 Genomics Inc, Akoya Biosciences Inc, RareCyte Inc, Standard BioTools, Rebus Biosystems Inc, Vizgen Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL OMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Spatial Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Spatial Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL OMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL OMICS MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Instrumental Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL OMICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. FFPE Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Fresh Frozen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL OMICS MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Academic & Translational Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SPATIAL OMICS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Technology
  • 9.2.2 By Product
  • 9.2.3 By Workflow
  • 9.2.4 By Sample Type
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Technology
  • 9.3.2 By Product
  • 9.3.3 By Workflow
  • 9.3.4 By Sample Type
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Technology
  • 9.4.2 By Product
  • 9.4.3 By Workflow
  • 9.4.4 By Sample Type
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Technology
  • 9.5.2 By Product
  • 9.5.3 By Workflow
  • 9.5.4 By Sample Type
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Technology
  • 9.6.2 By Product
  • 9.6.3 By Workflow
  • 9.6.4 By Sample Type
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL SPATIAL OMICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 10x Genomics
  • 11.2.2 Bio-Techne
  • 11.2.3 Bruker
  • 11.2.4 Dovetail Genomics
  • 11.2.5 S2 Genomics Inc
  • 11.2.6 Akoya Biosciences Inc
  • 11.2.7 RareCyte Inc
  • 11.2.8 Standard BioTools
  • 11.2.9 Rebus Biosystems Inc
  • 11.2.10 Vizgen Inc